Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7952 results

Sort By:

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

Study ID: NCT06072131
Start Date: 2023-10-04
End Date: 2030-11
Study Type

Interventional

Study Phase

Phase3

No. of Participants

504

Intervention / Treatment

Belinostat injection

Pralatrexate Injection

CHOP

COP

Sponsor

Acrotech Biopharma Inc.

Source: clinicaltrials.gov

Share:
Add to list

18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas

Study ID: NCT04895631
Start Date: 2021-06-30
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

140

Intervention / Treatment

18F-Fluorocholine

Positron emission tomography (PET)

Sponsor

Thomas Hope

Source: clinicaltrials.gov

Share:
Add to list

A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC

Study ID: NCT05394831
Start Date: 2023-07-30
End Date: 2025-11-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

150

Intervention / Treatment

Jin-A02

Sponsor

I INTS BIO

Source: clinicaltrials.gov

Share:
Add to list

Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes

Study ID: NCT03399773
Start Date: 2022-05-10
End Date: 2027-09-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

35

Intervention / Treatment

Dilanubicel

Cyclophosphamide

Fludarabine

Thiotepa

Total-Body Irradiation

Umbilical Cord Blood Transplantation

Laboratory Biomarker Analysis

Biospecimen Collection

Bone Marrow Aspirate

Bone Marrow Biopsy

Multigated Acquisition Scan

Electrocardiography

Computed Tomography

Sponsor

Fred Hutchinson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer

Study ID: NCT05319873
Start Date: 2022-04-07
End Date: 2026-04-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

18

Intervention / Treatment

Carboplatin

Docetaxel

Fulvestrant

Pertuzumab

Quality-of-Life Assessment

Ribociclib

Trastuzumab

Tucatinib

Sponsor

Jonsson Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Study ID: NCT05538091
Start Date: 2023-05-15
End Date: 2028-04-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

48

Intervention / Treatment

All the modegib

Atezolizumab

Sponsor

Ronald Buckanovich

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies

Study ID: NCT06719362
Start Date: 2025-10
End Date: 2030-02
Study Type

Interventional

Study Phase

Phase1

No. of Participants

110

Intervention / Treatment

M3T01

Pembrolizumab

Chemoradiation

FOLFOX regimen

Sponsor

Providence Health & Services

Source: clinicaltrials.gov

Share:
Add to list

Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer

Study ID: NCT03975231
Start Date: 2020-09-14
End Date: 2025-10-04
Study Type

Interventional

Study Phase

Phase1

No. of Participants

6

Intervention / Treatment

Dabrafenib

Intensity-Modulated Radiation Therapy

Trametinib

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic

Study ID: NCT06329531
Start Date: 2024-07-12
End Date: 2027-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS)

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)

Study ID: NCT05657873
Start Date: 2022-12-09
End Date: 2025-12-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

68

Intervention / Treatment

L-SABR

Anti-PD-(L)1 based immunotherapy

Platinum based chemotherapy

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list